Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2010 May 27;25(2):119–126. doi: 10.1007/s12291-010-0023-0

Polymorphisms in the vitamin D receptor and the androgen receptor gene associated with the risk of urolithiasis

Rama Devi Mittal 1,2,✉, D K Mishra 1, P Srivastava 1, P Manchanda 1, H K Bid 1, R Kapoor 1
PMCID: PMC3453098  PMID: 23105897

Abstract

Transcriptional activity of the vitamin D receptor (VDR) gene is regulated by androgen receptor (AR) gene and both are associated with renal stone formation. We examined gene polymorphisms of VDR (PCR-RFLP) and AR (GeneScan analysis) in 125 stone formers and 150 controls from north India. Genotype Ff of Fok-I and Tt of Taq-I demonstrated significantly higher risk (P<0.001, OR=3.559 and P=0.019, 1.830 respectively). Variant f allele exhibited 1.7-folds higher risk. Ff of Fok-I and Aa of Apa-I gene polymorphism showed higher risk in males only. Mean CAG repeat was significantly higher in hypercalciuric patients as compared to normocalciuric (mean=21.62 ± 3.384 vs. 20.11 ± 3.182; P=0.034). Combined effects 1.8-folds higher risk in patients with Tt genotype of Taq-I and short CAG repeat. Thus, association of FokI and TaqI VDR gene polymorphisms suggest VDR as an important genetic marker for urolithiasis. Further, patients with combination of Tt of Taq-I and short CAG repeat were at higher risk for stone formation.

Key Words: Androgen receptor, Polymorphism, Urolithiasis, Vitamin D receptor

Full Text

The Full Text of this article is available as a PDF (115.9 KB).

References

  • 1.Rendina D., Mossetti G., Viceconti R., Sorrentino M., Castaldo R., Manno G., et al. Association between vitamin D receptor gene Polymorphisms and fasting idiopathic Hypercalciuria in recurrent Stone-forming patients. Urol. 2004;64:833–838. doi: 10.1016/j.urology.2004.05.013. [DOI] [PubMed] [Google Scholar]
  • 2.Gao B., Yasui T., Itoh Y., Tozawa K., Hayashi Y., Kohri K. A Polymorphism of matrix Gla protein gene is associated with kidney stones. J Urol. 2007;177:2361–2365. doi: 10.1016/j.juro.2007.01.118. [DOI] [PubMed] [Google Scholar]
  • 3.Chen W.C., Wu H.C., Lin W.C., Wu M.C., Hsu C.D., Tsai F.J. The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men. BJU Int. 2001;88:432–436. doi: 10.1046/j.1464-410X.2001.02319.x. [DOI] [PubMed] [Google Scholar]
  • 4.Aswegen C.H., Hurter P., Merwe C.A., Plessis D.J. The relationship between total urinary testosterone and renal calculi. Urol Res. 1989;17:181–183. doi: 10.1007/BF00256248. [DOI] [PubMed] [Google Scholar]
  • 5.Dunning A.M., McBride S., Gregory J., Durocher F., Foster N.A., Healey C.S., et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis. 1999;20:2131–2135. doi: 10.1093/carcin/20.11.2131. [DOI] [PubMed] [Google Scholar]
  • 6.Slattery M.L., Murtaugh M., Caan B., Wolff R., Ma K.N., Samowitz W. Association between dietary fats and VDR genotypes and colon and rectal cancers. Int J Cancer Prev. 2004;1:193–205. [Google Scholar]
  • 7.Peehl D.M., Feldman D. Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer. J Steroid Biochem Mol Biol. 2004;92:307–315. doi: 10.1016/j.jsbmb.2004.10.006. [DOI] [PubMed] [Google Scholar]
  • 8.Zamuda J.M., Cauley J.A., Ferrell R.E. Molecular epidemiological of Vitamin D receptor variants. Epidemiol Rev. 2000;22:203–217. doi: 10.1093/oxfordjournals.epirev.a018033. [DOI] [PubMed] [Google Scholar]
  • 9.Bid H.K., Mishra D.K., Mittal R.D. Vitamin-D Receptor (VDR) Gene (Fok-I, Taq-I & Apa-I) Polymorphisms in Healthy Individuals from North Indian Population. Asian Pac J Cancer Prev. 2005;6:147–152. [PubMed] [Google Scholar]
  • 10.Nagaba Y., Heishi M., Tazawa H.Y., Tsukamoto Y., Kobayashi Y. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients. Am J Kid Dis. 1998;32:464–469. doi: 10.1053/ajkd.1998.v32.pm9740163. [DOI] [PubMed] [Google Scholar]
  • 11.Goodman H.O., Holmes R.P., Assimos D.G. Genetic factors in calcium oxalate stone disease. J Urol. 1995;153:301–307. doi: 10.1097/00005392-199502000-00003. [DOI] [PubMed] [Google Scholar]
  • 12.Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., Sambrook P.N., Eisman J.A. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;20:284–287. doi: 10.1038/367284a0. [DOI] [PubMed] [Google Scholar]
  • 13.Wieacker P.F., Knoke I., Jakubiczka S. Clinical and molecularaspects of androgen receptor defects. Exp Clin Endocrinol Diabetes. 1998;106:446–453. doi: 10.1055/s-0029-1212014. [DOI] [PubMed] [Google Scholar]
  • 14.Edwards A., Hammond H.A., Jin L., Caskey C.T., Chakraborty R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics. 1992;12:241–253. doi: 10.1016/0888-7543(92)90371-X. [DOI] [PubMed] [Google Scholar]
  • 15.Chamberlain N.L., Driver E.D., Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994;22:3181–3186. doi: 10.1093/nar/22.15.3181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mitsumori K., Terai A., Oka H., Segawa T., Ogura K., Yoshida O., Ogawa O. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate. 1999;41:253–257. doi: 10.1002/(SICI)1097-0045(19991201)41:4&#x0003c;253::AID-PROS5&#x0003e;3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  • 17.Chen W.C., Chen H.Y., Lu H.F., Hsu C.D., Tsai F.J. Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease. BJU Int. 2001;87:168–171. doi: 10.1046/j.1464-410x.2001.02074.x. [DOI] [PubMed] [Google Scholar]
  • 18.Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Harris S.S., Eccleshall T.R., Gross C., Dawson-Hughes B., Feldman D. The vitamin D receptor start codon polymorphism (Fok-1) and bone mineral density in premenopausal American Black and White women. J Bone Miner Res. 1997;12:1043–1048. doi: 10.1359/jbmr.1997.12.7.1043. [DOI] [PubMed] [Google Scholar]
  • 20.Riggs B.L., Nguyen T.V., Melton L.J., 3rd, Morrison N.A., O’Fallon W.M., Kelly P.J., et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res. 1995;10:991–996. doi: 10.1002/jbmr.5650100622. [DOI] [PubMed] [Google Scholar]
  • 21.Sainz J., Tornout J.M., Loro M.L., Sayre J., Roe T.F., Gilsanz V. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med. 1997;337:77–82. doi: 10.1056/NEJM199707103370202. [DOI] [PubMed] [Google Scholar]
  • 22.Cram D.S., Song B., McLachlan R.I., Trounson A.O. CAG trinucleotide repeats in the androgen receptor gene of infertile men exhibit stable inheritance in female offspring conceived after ICSI. Mol Hum Reprod. 2000;6:861–966. doi: 10.1093/molehr/6.9.861. [DOI] [PubMed] [Google Scholar]
  • 23.Valdivielso J.M., Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta. 2006;371:1–12. doi: 10.1016/j.cca.2006.02.016. [DOI] [PubMed] [Google Scholar]
  • 24.Arai H., Miyamoto K., Taketani Y., Yamamoto H., Iemori Y., Morita K., et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997;12:915–921. doi: 10.1359/jbmr.1997.12.6.915. [DOI] [PubMed] [Google Scholar]
  • 25.Relan V., Khullar M., Singh S.K., Sharma S.K. Association of vitamin d receptor genotypes with calcium excretion in nephrolithiatic subjects in northern India. Urol Res. 2004;32:236–240. doi: 10.1007/s00240-004-0414-x. [DOI] [PubMed] [Google Scholar]
  • 26.Vezzoli G., Soldati L., Proverbio M.C., Adamo D., Rubinacci A., Bianchi G., et al. Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. J Nephrol. 2002;15:158. [PubMed] [Google Scholar]
  • 27.Bid H.K., Chaudhary H., Mittal R.D. Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatr Nephrol. 2005;20:773–776. doi: 10.1007/s00467-005-1846-4. [DOI] [PubMed] [Google Scholar]
  • 28.Nishijima S., Sugaya K., Naito A., Morozumi M., Hatano T., Ogawa Y. Association of vitamin D receptor gene polymorphism with urolithiasis. J Urol. 2002;167:2188. doi: 10.1016/S0022-5347(05)65126-9. [DOI] [PubMed] [Google Scholar]
  • 29.Ozkaya O., Soylemezoglu O., Misirlioglu M., Gonen S., Buyan N., Hasanoglu E. Polymorphisms in the vitamin D receptor gene and the risk of calcium nephrolithiasis in children. Eur Urol. 2003;44:150. doi: 10.1016/S0302-2838(03)00206-9. [DOI] [PubMed] [Google Scholar]
  • 30.Sezgin G., Bilen C.Y., Asci N.K.R., Bagci H., Yilmaz A.F. Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol Res. 2006;34:47–52. doi: 10.1007/s00240-005-0033-1. [DOI] [PubMed] [Google Scholar]
  • 31.Lee Y.H., Huang W.C., Chiang H., Chen M.T., Huang J.K., Chang L.S. Determination role of testosterone in the pathogenesis of urolithiasis in rats. J Urol. 1992;147:1134–1138. doi: 10.1016/s0022-5347(17)37502-x. [DOI] [PubMed] [Google Scholar]
  • 32.Lee Y.H., Huang W.C., Huang J.K., Chang L.S. Testosterone enhances whereas estrogen inhibit calcium oxalate stone formation in ethylene glycol treated rats. J Urol. 1996;156:502–505. doi: 10.1016/S0022-5347(01)65914-7. [DOI] [PubMed] [Google Scholar]
  • 33.Curhan G.C. Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis. J Endourol. 1999;13:629–631. doi: 10.1089/end.1999.13.629. [DOI] [PubMed] [Google Scholar]
  • 34.Murthy S., Agoulnik I.U., Weigel N.L. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Prostate. 2005;64:362–372. doi: 10.1002/pros.20251. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES